Science Current Events | Science News | Brightsurf.com
 
Email a Friend Send to a friend
Printer Friendly Print MIT: Extending the shelf life of antibody drugs

MIT: Extending the shelf life of antibody drugs

June 30, 2009

New model allows researchers to design more stable drugs

CAMBRIDGE, Mass.--A new computer model developed at MIT can help solve a problem that has plagued drug companies trying to develop promising new treatments made of antibodies: Such drugs have a relatively short shelf life because they tend to clump together, rendering them ineffective.




Antibodies are the most rapidly growing class of human drugs, with the potential to treat cancer, arthritis and other chronic inflammatory and infectious diseases. About 200 such drugs are now in clinical trials, and a few are already on the market.

Patients can administer these drugs to themselves, but this requires high doses - and the drugs must therefore be stored at high concentrations. However, under these conditions the drugs tend to clump, or aggregate. Even if they are stored at lower concentrations and administered by a doctor intravenously, they often have stability issues. Addressing such issues typically takes place later in the drug development process, and the cost - both in time and money - is often high.

Currently there is no straightforward way to address these storage issues early in the development process.

"Drugs are usually developed with the criteria of how effective they'll be, and how well they'll bind to whatever target they're supposed to bind," says Bernhardt Trout, professor of chemical engineering and leader of the MIT team. "The problem is there are all of these issues down the line that were never taken into account."

Trout and his colleagues, including Bernhard Helk of Novartis, have developed a computer model that can help designers identify which parts of an antibody are most likely to attract other molecules, allowing them to alter the antibodies to prevent such clumping. The model, which the researchers aim to incorporate in the drug discovery process, is described in a paper appearing in the online edition of the Proceedings of the National Academy of Sciences the week of June 29.

Preventing aggregation

Most of the aggregation seen in antibodies is due to interactions between exposed hydrophobic (water-fearing) regions of the proteins.

Trout's new model, known as SAP (spatial aggregation propensity), offers a dynamic, three-dimensional simulation of antibody molecules. Unlike static representations such as those provided by X-ray crystallography, the new model can reveal hydrophobic regions and also indicates how much those regions are exposed when the molecule is in solution. The other important aspect of the model is that it selects out regions responsible for aggregation, as opposed to just single sites.

Once the hydrophobic regions are known, researchers can mutate the amino acids in those regions to decrease hydrophobicity and make the molecule more stable. Using the model, the team produced mutated antibodies with greatly enhanced stability (up to 50 percent more than the original antibodies), and the mutations had no adverse affect on their function.

Massachusetts Institute of Technology



Related Antibodies Current Events and Antibodies News Articles Antibodies Current Events and Antibodies News RSS Antibodies Current Events and Antibodies News RSS
New Synthetic Molecules Trigger Immune Response to HIV and Prostate Cancer
Researchers at Yale University have developed synthetic molecules capable of enhancing the body's immune response to HIV and HIV-infected cells, as well as to prostate cancer cells. Their findings, published online in the Journal of the American Chemical Society, could lead to novel therapeutic approaches for these diseases.

Common Pain Relievers May Dilute Power of Flu Shots
With flu vaccination season in full swing, research from the University of Rochester Medical Center cautions that use of many common pain killers - Advil, Tylenol, aspirin - at the time of injection may blunt the effect of the shot and have a negative effect on the immune system.

PATH Malaria Vaccine Initiative shares strategy for developing 'next-generation' malaria vaccines
Marking its tenth anniversary year, the PATH Malaria Vaccine Initiative (MVI) today unveiled a new strategy that sets the stage for an aggressive push targeting the long-term goal of eliminating and eradicating malaria. Malaria is one of the world's deadliest infectious diseases, killing nearly 900,000 people a year, most of them children in sub-Saharan Africa.

Study reveals a 'missing link' in immune response to disease
The immune system's T cells have the unique responsibilities of being both jury and executioner. They examine other cells for signs of disease, including cancers or infections, and, if such evidence is found, rid them from the body. Precisely how T cells shift so swiftly from one role to another, however, has been a mystery.

Breakthrough in industrial-scale nanotube processing
Rice University scientists today unveiled a method for the industrial-scale processing of pure carbon-nanotube fibers that could lead to revolutionary advances in materials science, power distribution and nanoelectronics.

Breakthrough in fight against Hendra virus
There has been a breakthrough in the fight against the deadly Hendra virus following the development of a treatment which shows great potential to save the lives of people who become infected with the virus.

USU scientists report major advance in human antibody therapy against deadly Nipah virus
A collaborative research team from the Uniformed Services University of the Health Sciences (USU), Australian Animal Health Laboratory and National Cancer Institute, a component of the National Institutes of Health, reports a major step forward in the development of an effective therapy against two deadly viruses, Nipah virus and the related Hendra virus.

Caltech researchers show efficacy of gene therapy in mouse models of Huntington's disease
Researchers at the California Institute of Technology (Caltech) have shown that a highly specific intrabody (an antibody fragment that works against a target inside a cell) is capable of stalling the development of Huntington's disease in a variety of mouse models.

Immunotherapy demonstrates long-term success in treating lymphoma
Targeted immunotherapy has been an attractive new therapeutic area for a number of cancers because it has the potential to destroy tumor cells without damaging surrounding normal tissue. New study results demonstrate high success rates using specialized white blood cells to prevent or treat lymphoma associated with the Epstein-Barr virus (EBV-lymphoma) in patients who have received a hematopoietic stem cell transplant (HSCT).

Exploring the final frontier: Disease proposed as major barrier to Mars and beyond
New research published in the Journal of Leukocyte Biology suggests that prolific virulence and growth of bacteria, coupled with reduced production of antibodies could limit future space travel.
More Antibodies Current Events and Antibodies News Articles
Antibodies (Two-Disc Special Edition)

Antibodies (Two-Disc Special Edition)
Starring: Norman Reedus, Christian von Aster, André Hennicke, Waltraud Witte, Konstantin Graudus
Directed By: Christian Alvart

Studio: Mpi Home Video Release Date: 08/28/2007 Run time: 128 minutes

Antibodies: A Laboratory Manual

Antibodies: A Laboratory Manual
by Ed Harlow (Author), David Lane (Author)

Introduction to immunochemistry for molecular biologists and other nonspecialists. Spiral.

Chronicle of an Escape

Chronicle of an Escape
Starring: Rodrigo De la Serna, Pablo Echarri, Nazareno Casero, Lautaro Delgado, Matías Marmorato
Directed By: Adrián Caetano
Also With: Adrián Caetano (Writer), Alejandra Dixon (Producer), Hugo Sigman (Producer), Paula Zyngierman (Producer), Claudio Tamburrini (Writer), Esteban Student (Writer), Julian Loyola (Writer)

A soccer player is suddenly ripped from the field and finds himself on the floor of a horrific detention center. What follows is a living hell of interrogations and relentless mental and physical abuse. Alongside other young detainees, he battles to survive while awaiting his fate to be decided. With execution looking certain, he and three other prisoners will risk their lives and make a desperate and extraordinarily brave move for freedom.

Making and Using Antibodies: A Practical Handbook

Making and Using Antibodies: A Practical Handbook
by Gary C. Howard (Editor), Matthew R. Kaser (Editor)

Antibodies are an indispensable tool in the study of biology and medicine. Making and Using Antibodies: A Practical Handbook presents techniques in a single, comprehensive source for the production and use of antibodies. It enables researchers to immediately access lab-tested, proven protocols.

Written and edited by an elite team of scientists, who have developed and refined many of the methods, this book covers-
Commercially available adjuvants designed for the production of antisera in the research setting
Methods for the production, purification, and characterization of antibodies
Practical guidance to researchers needing to modify antibodies
Basic techniques including enzyme-linked immunosorbent assay (ELISA), Western blotting, immunohistochemistry, and flow...

Punish Me

Punish Me
Starring: Ullman; Kroymann; Vollenklee
Directed By: Angelina Maccarone

Jan is a 16-year-old juvenile delinquent placed under the watchful eye of Elsa Seifert, a stern, driven, and uncompromising 49-year-old probation officer. Elsa cares for her charges, but tolerates no stepping out of line. But now, as she approaches 50, cracks begin to appear in Elsa's professionalism. As her grown daughter prepares to leave home, and her marriage becomes more and more strained, Elsa longs for the intensity of experiencing something outside of her routine, something outside the norm.

Young, obsessed, Jan eagerly fills this void, offering to sexually subjugate himself to her. And Elsa enters willingly into this risky venture, desiring the verboten, but knowing it cannot end well.

Winner of the Golden Leopard prize at the 2006 Locarno Film Festival, PUNISH ME...

Monoclonal Antibodies in Biotechnology: Theoretical and Practical Aspects (Cambridge Studies in Biotechnology)

Monoclonal Antibodies in Biotechnology: Theoretical and Practical Aspects (Cambridge Studies in Biotechnology)
by Kenneth C. McCullough (Author), Raymond E. Spier (Author)

This volume provides a complete description of the principles, methodologies and applications of monoclonal antibodies, one of the most exciting developments to occur in biotechnology in recent years, and a powerful technology for modern industry and science. The immune system and the role of the antibody are described and full details are given on how the hybridomas are formed, isolated, and maintained in culture such that the required antibody can be produced to a high degree of purity. The authors describe all the methodologies involved, all the reagents and solutions and all the assay conditions required for their production. The material is presented to enable research and development managers to make choices as to which are the most suitable techniques for their requirements. The...

  Antibodies



Monoclonal Antibodies: Methods and Protocols (Methods in Molecular Biology)

Monoclonal Antibodies: Methods and Protocols (Methods in Molecular Biology)
by Maher Albitar (Editor)

Monoclonal Antibodies: Methods and Protocols examines a collection of state-of-the-art methods that employ monoclonal antibodies in a clinical setting with opening chapters focusing on the gold standard method for generating mouse monoclonal antibodies through hybridoma technology, future methods for engineering recombinant and humanized antibodies, methods for engineering soluble Fc fusion protein, and the use of antibodies and flow cytometry in the quantification of cell signaling proteins. Specific chapters describe how antibodies are used for the diagnosis and classification of hematologic diseases. Subsequent chapters examine the advantages and most recent advances of using bead-based immunoassays, including the ability of bead-based technology to multiplex and analyze several...

  Human Antibodies
by Ios Press



Trip on Cocaine

Trip on Cocaine
Strange Antibody (Primary Contributor)



© 2009 BrightSurf.com